Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiang Deng

Showing results (431-440 of 436) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 436 results.
Cell|August 16, 2020
A Thermostable mRNA Vaccine against COVID-19Na-Na Zhang, Xiao-Feng Li, Yong-Qiang Deng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014Chang-Qing Bai, Jin-Song Mu, David Kargbo, et al.
The Lancet. Microbe|January 31, 2022
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialGui-Ling Chen, Xiao-Feng Li, Xia-Hong Dai, et al.
The Journal of Infectious Diseases|May 13, 2017
Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary AnalysesTao Jiang, Jia-Fu Jiang, Yong-Qiang Deng, et al.
Cell Research|December 2, 2020
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protectionHangping Yao, Yao Sun, Yong-Qiang Deng, et al.
Nature|May 14, 2015
Genetic diversity and evolutionary dynamics of Ebola virus in Sierra LeoneYi-Gang Tong, Wei-Feng Shi, Di Liu, et al.
Pageof 44

Showing results (431-440 of 436) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 436 results.
Cell|August 16, 2020
A Thermostable mRNA Vaccine against COVID-19Na-Na Zhang, Xiao-Feng Li, Yong-Qiang Deng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014Chang-Qing Bai, Jin-Song Mu, David Kargbo, et al.
The Lancet. Microbe|January 31, 2022
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialGui-Ling Chen, Xiao-Feng Li, Xia-Hong Dai, et al.
The Journal of Infectious Diseases|May 13, 2017
Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary AnalysesTao Jiang, Jia-Fu Jiang, Yong-Qiang Deng, et al.
Cell Research|December 2, 2020
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protectionHangping Yao, Yao Sun, Yong-Qiang Deng, et al.
Nature|May 14, 2015
Genetic diversity and evolutionary dynamics of Ebola virus in Sierra LeoneYi-Gang Tong, Wei-Feng Shi, Di Liu, et al.
Pageof 44